Compounded semaglutide should be stopped at least two months before trying to conceive, following the same guidance that applies to brand-name semaglutide products. The active molecule is identical, meaning the same fertility precautions and washout timeline apply. At the same time, the weight loss compounded semaglutide provides may improve fertility for patients dealing with obesity-related reproductive challenges.

Compounded semaglutide has become a popular option for weight management, particularly for patients seeking more affordable access to GLP-1 therapy. Many of these patients are women of childbearing age who need clear guidance about how this medication relates to their reproductive plans.

Washout Period and Pregnancy Planning

Semaglutide, whether compounded or brand-name, has a half-life of approximately seven days. The two-month washout recommendation allows the drug to go through roughly eight half-lives, reducing circulating levels to negligible amounts.

This recommendation comes from animal reproductive studies that showed adverse fetal outcomes at doses higher than those used in humans. Because controlled human pregnancy data does not exist, the conservative approach is to ensure the drug is fully cleared before conception. Your prescriber can help you plan the transition from treatment to trying to conceive.

Weight Loss Benefits for Reproductive Health

Excess body weight interferes with fertility through several mechanisms: hormonal imbalances driven by adipose tissue, insulin resistance that disrupts ovulation, chronic low-grade inflammation, and increased pregnancy complication risks.

Compounded semaglutide addresses these issues by promoting meaningful weight loss. Patients often lose 10% to 15% of their body weight, which can:

• Restart regular ovulatory cycles in women who had stopped ovulating
• Improve IVF and IUI success rates
• Normalize reproductive hormone levels in both men and women
• Lower the risk of miscarriage associated with obesity
• Create a healthier metabolic environment for pregnancy

Compounding and Fertility: A Special Note

One question unique to compounded semaglutide is whether the compounding process affects safety differently than brand-name products. The active molecule in compounded semaglutide is the same as in Ozempic and Wegovy. However, compounded medications are prepared by specialty pharmacies rather than the original manufacturer, and the inactive ingredients (excipients) may vary. compounded semaglutide

From a fertility standpoint, the key safety considerations remain the same: stop at least two months before conception, use reliable contraception during treatment, and communicate with your provider about your family planning timeline. The washout period and precautions apply equally regardless of whether your semaglutide is compounded or brand-name.

Contraception During Treatment

Because semaglutide slows gastric emptying, there is a theoretical concern about reduced absorption of oral contraceptive pills. While this has not been definitively proven to cause contraceptive failure with semaglutide specifically, many providers recommend using a non-oral backup method or switching to a non-oral contraceptive altogether during treatment. IUDs, implants, and injectable contraceptives are not affected.

Frequently Asked Questions